Heyu Biological Technology Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HYBT research report →
Companyheyubt.com
Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. It is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc.
- CEO
- Ban Siong Ang
- IPO
- 1999
- HQ
- Xiamen, CN
Price Chart
Valuation
- Market Cap
- $361.36M
- P/E
- 241.19
- P/S
- 31.76
- P/B
- 4.29
- EV/EBITDA
- 327.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 17.34%
- Op Margin
- 8.16%
- Net Margin
- 6.62%
- ROE
- 1.84%
- ROIC
- 1.62%
Growth & Income
- Revenue
- $2.87M · 7.14%
- Net Income
- $-472,000 · -24.54%
- EPS
- $-0.00 · -12.50%
- Op Income
- $-377,401
- FCF YoY
- 71.49%
Performance & Tape
- 52W High
- $3.40
- 52W Low
- $0.00
- 50D MA
- $0.46
- 200D MA
- $1.10
- Beta
- -17.89
- Avg Volume
- 498
Get TickerSpark's AI analysis on HYBT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 28, 23 | Ang Ban Siong | sell | 28,328,194 |
| Sep 4, 23 | Gao Xingjia | other | 0 |
| Sep 4, 23 | Li Wei | other | 0 |
| Sep 1, 23 | Lin Zengqiang | other | 0 |
| Sep 1, 23 | Lin Zhenzhu | other | 0 |
| May 17, 23 | TAN HUNG SENG | buy | 20,000,000 |
| May 17, 23 | Ang Ban Siong | sell | 68,645,429 |
| Mar 20, 19 | Ang Ban Siong | sell | 109,006,861 |
| Apr 12, 18 | Master Daniel C | other | 0 |
| Aug 7, 17 | Master Daniel C | buy | 0 |
Our HYBT Coverage
We haven't published any research on HYBT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HYBT Report →